ZBTB16 was also down-regulated in never smoker patients with lung adenocarcinoma [46] and non-small cell lung cancer high-metastatic cell line compared with the low-metastatic cell line [47]. Here, ZBTB16 is linked to non-small cell lung carcinoma.